FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1502077872> ?p ?o ?g. }

• W1502077872 endingPage "388" @default.
• W1502077872 startingPage "378" @default.
• W1502077872 abstract "There is no consensus on the selection of specific drug therapies when metformin fails in Type 2 diabetes (T2D). This meta-analysis was performed to determine the efficacy and safety of Dipeptidyl peptidase-4 inhibitors (DPP4-I) compared to sulfonylurea (SU) as add-on therapy to metformin in inadequately controlled T2D patients. We searched MEDLINE, CENTRAL, EMBASE, and CINAHL for randomized trials comparing DPP4-I to SU as add-on therapy to metformin and reported a change in hemoglobin A1c (HbA1c). Sixteen articles were included. There was a significantly greater reduction in HbA1c from baseline to 12 weeks with SU versus DPP4-I (MD[95% CI]=0.21%(2 mmol/mol) [0.06, 0.35]) but no significant difference at 52 and 104 weeks (MD[95% CI]=0.06%(-1 mmol/mol) [-0.03, 0.15] and 0.02%(-1 mmol/mol) [-0.13,0.18] respectively). SU was associated with weight gain and DPP4-I with weight loss at all time-points. The incidence of hypoglycemia at 12, 52, and 104 weeks was significantly greater with SU (20%, 24%, and 27% respectively) compared to DPP4-I (6%, 3%, and 4% respectively). The proportion of patients with HbA1c<7%(53 mmol/mol) without hypoglycemia was significantly higher at 52 and 104 weeks among patients on DPP4-I (RR[95% CI]=1.20 [1.05, 1.37] and 1.53 [1.16, 2.02] respectively). There was no significant difference between the two groups in the incidence of other side effects. While both SU and DPP4-I can be considered as options for add-on therapy to metformin in inadequately controlled T2D, SU results in a significantly increased risk of hypoglycemia and weight gain. By contrast, DPP4-I produce 0.4-0.6% (4-7 mmol/mol) reduction in HbA1c, lower risk of hypoglycemia, and weight loss." @default.
• W1502077872 created "2016-06-24" @default.
• W1502077872 creator A5027721713 @default.
• W1502077872 creator A5064245192 @default.
• W1502077872 creator A5091612546 @default.
• W1502077872 date "2015-08-01" @default.
• W1502077872 modified "2023-10-16" @default.
• W1502077872 title "The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-analysis" @default.
• W1502077872 cites W1532170875 @default.
• W1502077872 cites W1550171354 @default.
• W1502077872 cites W1562360472 @default.
• W1502077872 cites W172609984 @default.
• W1502077872 cites W1973824615 @default.
• W1502077872 cites W1978630848 @default.
• W1502077872 cites W1981113379 @default.
• W1502077872 cites W1981478931 @default.
• W1502077872 cites W1983269691 @default.
• W1502077872 cites W1986215651 @default.
• W1502077872 cites W1988046391 @default.
• W1502077872 cites W1991951001 @default.
• W1502077872 cites W2002269706 @default.
• W1502077872 cites W2007682515 @default.
• W1502077872 cites W2010634433 @default.
• W1502077872 cites W2011992630 @default.
• W1502077872 cites W2018192866 @default.
• W1502077872 cites W2019513002 @default.
• W1502077872 cites W2033768383 @default.
• W1502077872 cites W2040766195 @default.
• W1502077872 cites W2083725441 @default.
• W1502077872 cites W2086570641 @default.
• W1502077872 cites W2087025850 @default.
• W1502077872 cites W2088937610 @default.
• W1502077872 cites W2094461218 @default.
• W1502077872 cites W2101244337 @default.
• W1502077872 cites W2102511839 @default.
• W1502077872 cites W2103828712 @default.
• W1502077872 cites W2107562831 @default.
• W1502077872 cites W2109468903 @default.
• W1502077872 cites W2110283887 @default.
• W1502077872 cites W2115574356 @default.
• W1502077872 cites W2118619033 @default.
• W1502077872 cites W2128243640 @default.
• W1502077872 cites W2131101359 @default.
• W1502077872 cites W2133244310 @default.
• W1502077872 cites W2158666727 @default.
• W1502077872 cites W2160298785 @default.
• W1502077872 cites W2172193326 @default.
• W1502077872 cites W2527670279 @default.
• W1502077872 cites W3022903699 @default.
• W1502077872 cites W4212897227 @default.
• W1502077872 cites W4242364069 @default.
• W1502077872 doi "https://doi.org/10.1016/j.diabres.2015.05.025" @default.
• W1502077872 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26059071" @default.
• W1502077872 hasPublicationYear "2015" @default.
• W1502077872 type Work @default.
• W1502077872 sameAs 1502077872 @default.
• W1502077872 citedByCount "73" @default.
• W1502077872 countsByYear W15020778722015 @default.
• W1502077872 countsByYear W15020778722016 @default.
• W1502077872 countsByYear W15020778722017 @default.
• W1502077872 countsByYear W15020778722018 @default.
• W1502077872 countsByYear W15020778722019 @default.
• W1502077872 countsByYear W15020778722020 @default.
• W1502077872 countsByYear W15020778722021 @default.
• W1502077872 countsByYear W15020778722022 @default.
• W1502077872 countsByYear W15020778722023 @default.
• W1502077872 crossrefType "journal-article" @default.
• W1502077872 hasAuthorship W1502077872A5027721713 @default.
• W1502077872 hasAuthorship W1502077872A5064245192 @default.
• W1502077872 hasAuthorship W1502077872A5091612546 @default.
• W1502077872 hasConcept C120665830 @default.
• W1502077872 hasConcept C121332964 @default.
• W1502077872 hasConcept C126322002 @default.
• W1502077872 hasConcept C134018914 @default.
• W1502077872 hasConcept C156490143 @default.
• W1502077872 hasConcept C168563851 @default.
• W1502077872 hasConcept C2777180221 @default.
• W1502077872 hasConcept C2778854520 @default.
• W1502077872 hasConcept C2779306644 @default.
• W1502077872 hasConcept C2780323712 @default.
• W1502077872 hasConcept C2780668416 @default.
• W1502077872 hasConcept C555293320 @default.
• W1502077872 hasConcept C61511704 @default.
• W1502077872 hasConcept C71924100 @default.
• W1502077872 hasConcept C90924648 @default.
• W1502077872 hasConcept C95190672 @default.
• W1502077872 hasConceptScore W1502077872C120665830 @default.
• W1502077872 hasConceptScore W1502077872C121332964 @default.
• W1502077872 hasConceptScore W1502077872C126322002 @default.
• W1502077872 hasConceptScore W1502077872C134018914 @default.
• W1502077872 hasConceptScore W1502077872C156490143 @default.
• W1502077872 hasConceptScore W1502077872C168563851 @default.
• W1502077872 hasConceptScore W1502077872C2777180221 @default.
• W1502077872 hasConceptScore W1502077872C2778854520 @default.
• W1502077872 hasConceptScore W1502077872C2779306644 @default.
• W1502077872 hasConceptScore W1502077872C2780323712 @default.
• W1502077872 hasConceptScore W1502077872C2780668416 @default.
• W1502077872 hasConceptScore W1502077872C555293320 @default.

• next